每經(jing)AI快訊，傲農生物（SH 603363，收(shou)盤價：3.26元(yuan)）2月5日晚(wan)間發布公(gong)(gong)(gong)告稱，截至2023年12月31日，公(gong)(gong)(gong)司(si)(si)(si)及下(xia)屬全(quan)資(zi)(zi)(zi)、控(kong)股(gu)子(zi)(zi)公(gong)(gong)(gong)司(si)(si)(si)實(shi)際(ji)對外擔(dan)保(bao)余(yu)額約(yue)12.06億元(yuan)，占公(gong)(gong)(gong)司(si)(si)(si)最近一(yi)期(qi)經(jing)審計(ji)凈資(zi)(zi)(zi)產(chan)(chan)的(de)48.17%；公(gong)(gong)(gong)司(si)(si)(si)對下(xia)屬全(quan)資(zi)(zi)(zi)、控(kong)股(gu)子(zi)(zi)公(gong)(gong)(gong)司(si)(si)(si)實(shi)際(ji)擔(dan)保(bao)余(yu)額約(yue)為56.11億元(yuan)，占公(gong)(gong)(gong)司(si)(si)(si)最近一(yi)期(qi)經(jing)審計(ji)凈資(zi)(zi)(zi)產(chan)(chan)的(de)224.11%；下(xia)屬全(quan)資(zi)(zi)(zi)、控(kong)股(gu)子(zi)(zi)公(gong)(gong)(gong)司(si)(si)(si)為公(gong)(gong)(gong)司(si)(si)(si)其他下(xia)屬全(quan)資(zi)(zi)(zi)、控(kong)股(gu)子(zi)(zi)公(gong)(gong)(gong)司(si)(si)(si)實(shi)際(ji)擔(dan)保(bao)余(yu)額為約(yue)11.65億元(yuan)，占公(gong)(gong)(gong)司(si)(si)(si)最近一(yi)期(qi)經(jing)審計(ji)凈資(zi)(zi)(zi)產(chan)(chan)的(de)46.54%；下(xia)屬全(quan)資(zi)(zi)(zi)、控(kong)股(gu)子(zi)(zi)公(gong)(gong)(gong)司(si)(si)(si)為公(gong)(gong)(gong)司(si)(si)(si)實(shi)際(ji)擔(dan)保(bao)余(yu)額為約(yue)11.41億元(yuan)，占公(gong)(gong)(gong)司(si)(si)(si)最近一(yi)期(qi)經(jing)審計(ji)凈資(zi)(zi)(zi)產(chan)(chan)的(de)45.57%。

2023年1至6月份(fen)，傲農生物的營(ying)業(ye)(ye)收入(ru)構成為：飼(si)料及(ji)動保行(xing)業(ye)(ye)占比53.45%，飼(si)養行(xing)業(ye)(ye)占比28.42%，食品占比14.8%，貿易占比3.0%，其他(ta)占比0.01%。

傲農(nong)生物的總經理、董事(shi)長均是吳有林，男，46歲，學(xue)歷背景為大專。

截至發稿，傲農生物市值為(wei)28億(yi)元。

道達號(hao)（daoda1997）“個股趨(qu)勢”提醒：
1. 傲農生物近30日內北向資金持股量增加842.94萬股，占流通股比例增加1.15%；
2. 近30日(ri)內無機構對傲(ao)農生物進行(xing)調研。

每(mei)經頭條(tiao)（nbdtoutiao）——

(記者 曾健輝)

免責聲明(ming)：本文內容與(yu)數據僅供參考，不構成投資建議(yi)，使用前請核(he)實。據此操作，風險自擔。